Delivery Order SPE2D021DA002-SPE2D325F076Q
Award Date
5/22/25
Potential Completion Date
5/28/25
Potential Value
$16K
Federal Agency
Medical Supply Chain
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,362.08 contract is for the delivery of ENGERIX-B 20 MCG/ML SYRN, a hepatitis B vaccine, with a completion date of June 21, 2024. DMS Pharmaceutical Group holds a larger, single-award, indefinite-delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through...
This delivery order for $2,362.08 was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRN, a hepatitis B vaccine, to the Defense Logistics Agency (DLA) Medical Supply Chain. The order, placed under the DLA's SPE2DB program, has a firm fixed price and an ultimate completion date of July 12, 2024. DMS Pharmaceutical Group specializes in providing a wide range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,668.88 firm fixed-price contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger, single-award indefinite delivery contract (IDC) with the DLA, valued at up to...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $3,939.00, is for the delivery of ENGERIX-B 20 MCG/ML SYRN, a hepatitis B vaccine, with a period of performance through May 2, 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,969.50 firm fixed-price delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRN, a hepatitis B vaccine. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid through November 2026. The IDC...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,968.40 contract is for the delivery of 4,566,322,435 units of ENGERIX-B 20 MCG/ML SYRN, a specialized pharmaceutical product, with a period of performance through November 5, 2024. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract (IDC) with the DLA under...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a ceiling value of $1,969.50 and a period of performance through May 27, 2025. DMS Pharmaceutical Group has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract has a ceiling value of $8,330.56 and a performance period ending on June 14, 2024. This contract is not set aside for any specific business classification. DMS Pharmaceutical Group...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,818.72, is for the delivery of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract has an ultimate completion date of March 12, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,395.24 contract is for the delivery of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a specialized pharmaceutical product, with a completion date of April 10, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...